• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

未接种疫苗的既往 COVID-19 成年人中的 COVID-19 发病率。

Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19.

机构信息

Department of Medicine, University of Chicago, Chicago, Illinois.

Providence Research Network, Renton, Washington.

出版信息

JAMA Netw Open. 2022 Apr 1;5(4):e227650. doi: 10.1001/jamanetworkopen.2022.7650.

DOI:10.1001/jamanetworkopen.2022.7650
PMID:35442459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9021912/
Abstract

This cohort study compares rates of COVID-19 between unvaccinated adults who did and did not previously test positive for SARS-CoV-2.

摘要

这项队列研究比较了未接种疫苗且既往 SARS-CoV-2 检测呈阳性与阴性的成年人 COVID-19 发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3229/9021912/5e228a79edb7/jamanetwopen-e227650-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3229/9021912/5e228a79edb7/jamanetwopen-e227650-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3229/9021912/5e228a79edb7/jamanetwopen-e227650-g001.jpg

相似文献

1
Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19.未接种疫苗的既往 COVID-19 成年人中的 COVID-19 发病率。
JAMA Netw Open. 2022 Apr 1;5(4):e227650. doi: 10.1001/jamanetworkopen.2022.7650.
2
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日，加利福尼亚州洛杉矶县≥16 岁人群中，根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
3
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.COVID-19 相关住院病例在 SARS-CoV-2 德尔塔和奥密克戎变异株流行期间的种族/民族差异和疫苗接种状况分析——COVID-NET，14 个州，2021 年 7 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):466-473. doi: 10.15585/mmwr.mm7112e2.
4
Transmission of and Infection With COVID-19 Among Vaccinated and Unvaccinated Attendees of an Indoor Wedding Reception in Minnesota.明尼苏达州室内婚礼接待会上，接种疫苗和未接种疫苗的与会者之间 COVID-19 的传播和感染。
JAMA Netw Open. 2022 Feb 1;5(2):e220536. doi: 10.1001/jamanetworkopen.2022.0536.
5
Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.成人因实验室确诊的 COVID-19 住院的严重程度在 SARS-CoV-2 B.1.617.2（Delta）流行之前和期间-COVID-NET，14 个州，2021 年 1 月至 8 月。
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513-1519. doi: 10.15585/mmwr.mm7043e1.
6
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.2021 年 1 月至 9 月，九个州感染诱导或 mRNA 疫苗诱导的 SARS-CoV-2 免疫的具有 COVID-19 样疾病住院成人的实验室确诊 COVID-19。
MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1539-1544. doi: 10.15585/mmwr.mm7044e1.
7
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination.接种疫苗后出现突破性SARS-CoV-2感染患者的结局
Int J Infect Dis. 2021 Sep;110:353-358. doi: 10.1016/j.ijid.2021.08.008. Epub 2021 Aug 8.
8
Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.SARS-CoV-2 疫苗接种在妊娠期间的安全性-来自大型队列研究的产科结局。
BMC Pregnancy Childbirth. 2022 Feb 28;22(1):166. doi: 10.1186/s12884-022-04505-5.
9
Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.2021 年 7 月 4 日至 9 月 25 日，≥12 岁人群中 COVID-19 疫苗接种状况与 SARS-CoV-2 感染、因 COVID-19 前往急诊就诊和住院的关系 - 俄勒冈州和华盛顿。
MMWR Morb Mortal Wkly Rep. 2021 Nov 19;70(46):1608-1612. doi: 10.15585/mmwr.mm7046a4.
10
The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers' unvaccinated household members.mRNA 新冠疫苗接种对医护人员未接种疫苗的家庭成员的间接影响。
Nat Commun. 2022 Mar 4;13(1):1162. doi: 10.1038/s41467-022-28825-4.

引用本文的文献

1
Real-world clinical outcomes of tixagevimab/cilgavimab in the Omicron outbreak in China: baseline characteristics and interim analysis of the CLEAR study.在中国奥密克戎疫情期间替沙格韦单抗/西加韦单抗的真实世界临床结局：CLEAR 研究的基线特征和中期分析。
Virol J. 2024 Oct 24;21(1):262. doi: 10.1186/s12985-024-02509-5.
2
Persistence of T-Cell Immunity Responses against SARS-CoV-2 for over 12 Months Post COVID-19 Infection in Unvaccinated Individuals with No Detectable IgG Antibodies.未接种疫苗且未检测到IgG抗体的个体在感染新冠病毒12个月后针对严重急性呼吸综合征冠状病毒2的T细胞免疫反应持续存在。
Vaccines (Basel). 2023 Nov 27;11(12):1764. doi: 10.3390/vaccines11121764.
3

本文引用的文献

1
Protective immunity after recovery from SARS-CoV-2 infection.新型冠状病毒感染康复后的保护性免疫。
Lancet Infect Dis. 2022 Jan;22(1):12-14. doi: 10.1016/S1473-3099(21)00676-9. Epub 2021 Nov 8.
2
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.辉瑞-BioNTech 信使核糖核酸 COVID-19 疫苗在美国大型综合卫生系统中的 6 个月有效性：一项回顾性队列研究。
Lancet. 2021 Oct 16;398(10309):1407-1416. doi: 10.1016/S0140-6736(21)02183-8. Epub 2021 Oct 4.
3
Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis.
Contemporaneous SARS-CoV-2-Neutralizing Antibodies Mediated by N-glycan Shields.
由 N-聚糖盾牌介导的同时针对 SARS-CoV-2 的中和抗体。
Viruses. 2023 Oct 12;15(10):2079. doi: 10.3390/v15102079.
4
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample.SARS-CoV-2 感染的趋势和症状：对阿尔卑斯地区代表性人群的纵向研究。
BMJ Open. 2023 Jun 8;13(6):e072650. doi: 10.1136/bmjopen-2023-072650.
5
SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil.巴西关注变体 Gamma 再次感染后，SARS-CoV-2 宿主内多样性、抗体反应和疾病严重程度。
Sci Rep. 2023 May 5;13(1):7306. doi: 10.1038/s41598-023-33443-1.
6
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.瑞士一项多中心队列研究：根据德尔塔和奥密克戎变异株流行期间的基线免疫状态和加强针接种情况，评估卫生专业人员感染 COVID-19 的风险和症状。
PLoS Med. 2022 Nov 7;19(11):e1004125. doi: 10.1371/journal.pmed.1004125. eCollection 2022 Nov.
7
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.在加拿大魁北克省，mRNA 疫苗接种者和未接种者中，先前感染 SARS-CoV-2 对奥密克戎变异株再感染的估计保护作用。
JAMA Netw Open. 2022 Oct 3;5(10):e2236670. doi: 10.1001/jamanetworkopen.2022.36670.
自然感染或接种疫苗诱导的针对严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）变异株的中和抗体：系统评价和汇总分析。
Clin Infect Dis. 2022 Mar 1;74(4):734-742. doi: 10.1093/cid/ciab646.
4
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.BNT162b2 和 mRNA-1273 疫苗对新冠病毒的预防和衰减作用。
N Engl J Med. 2021 Jul 22;385(4):320-329. doi: 10.1056/NEJMoa2107058. Epub 2021 Jun 30.
5
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.2020 年丹麦对 400 万 PCR 检测个体进行的 SARS-CoV-2 再感染保护评估：一项基于人群的观察性研究。
Lancet. 2021 Mar 27;397(10280):1204-1212. doi: 10.1016/S0140-6736(21)00575-4. Epub 2021 Mar 17.
6
Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study.新冠病毒病 2019 既往阳性患者的再感染率：一项回顾性队列研究。
Clin Infect Dis. 2021 Nov 16;73(10):1882-1886. doi: 10.1093/cid/ciab234.